Discrepancies in Measured Factor VIII Activity in Patients Treated with Factor VIII Concentrate of Human or Porcine Origin

Thromb Haemost 2002; 88(01): 159-160
DOI: 10.1055/s-0037-1613171

Letters to the Editor

Schattauer GmbH

J. M. Teitel

¹Division of Hematology and Oncology, St. Michael’s Hospital. Toronto, Ontario, Canada

,

H. K. Lau

¹Division of Hematology and Oncology, St. Michael’s Hospital. Toronto, Ontario, Canada

,

M. B. Garvey

¹Division of Hematology and Oncology, St. Michael’s Hospital. Toronto, Ontario, Canada

References
1 Keeling DM, Sukhu K, Kemball-Cook G, Waseem N, Bagnall R, Lloyd JV. Diagnostic importance of the two-stage factor VIII:C assay demonstrated by a case of mild haemophilia associated with His¹⁹⁵⁴ → Leu substitution in the factor VIII A3 domain. Br J Haematol 1999; 105: 1123-26.
2 Schwaab R, Oldenburg J, Kemball-Cook G, Albert T, Juhler C, Hanfland P. Ingerslev J. Assay discrepancy in mild haemophilia A due to a factor VIII missense mutation (Asn694Ile) in a large Danish family. Br J Haematol 2000; 109: 523-28.
3 Roelse JC, De Laaf RTM, Mertens K, Van Mourik JA, Oldenburg J. Voorberg J. Altered sensitivity towards factor IXa explains assay discrepancies in plasma of haemophilia A patients with a GLU720LYS substitution in factor VIII. Thromb Haemost 1999; 82: 5a.
4 Lollar P, Parker ET. Structural basis for the decreased procoagulant activity of human factor VIII compared to the porcine homolog. J Biol Chem 1991; 266: 12481-86.
5 Aronson DL, Chang P. Activated factor VIII in therapeutic preparations: Analysis by ultracentrifugation. Vox Sang 1996; 71: 142-49.
6 Hay CRM, Bolton-Maggs P. Porcine factor VIIIC in the management of patients with factor VIII inhibitors. Transfus Med Rev 1991; 05: 145-51.